retatrutide phase 2 nejm 2023 obesity trial jastreboff 💉 may be redefining treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Phase 3 Trial of Semaglutide

Since d-allulose has sweet taste and an anorexigenic effect, consumption of d-allulose can decrease calorie intake while maintaining the pleasure of eating

Corsini EM, Mitchell KG, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG , Vaporciyan AA, Walsh GL, Antonoff MB, Rice DC

43 Semaglutide Semaglutide is a peptide drug composed of 31 amino acids linked with 18 carbon fatty acids (MW: 4113.6 g/mol) (Figure 1F)

Online versus offline friendship quantity and loneliness measurements

Evidence from randomized controlled trials suggests that OA-related knee pain and function improve with semaglutide but not with liraglutide treatment, and observational studies suggest that GLP-1RA use reduces the risk of surgery for knee OA